K223038

Substantially Equivalent

Access Cortisol

Applicant: Beckman Coulter, Inc.
Product code: CGR
Advisory panel: Clinical Chemistry
Date received: 2022-09-29
Decision date: 2023-02-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.